Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Predictive Oncology Inc (POAI)
NASDAQ:POAI
Predictive Oncology (POAI) Stock Price & Analysis
368 Followers
POAI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.35 - $7.12
Previous Close$1.39
Volume28.69K
Average Volume (3M)24.83K
Market Cap
$6.13M
Enterprise Value-$2.62M
Total Cash (Recent Filing)$11.92M
Total Debt (Recent Filing)$3.16M
Price to Earnings (P/E)-0.4
Beta2.72
Next Earnings
May 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.48
Shares Outstanding4,062,853
10 Day Avg. Volume27,486
30 Day Avg. Volume24,834
Standard Deviation0.23
R-Squared0.06
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.54
Price to Sales (P/S)3.75
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue-1.45
Enterprise Value/Gross Profit-2.62
Enterprise Value/Ebitda0.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Predictive Oncology News
Ownership Overview
67.57% Insiders
4.32% Mutual Funds
3.55% Other Institutional Investors
24.56% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
POAI FAQ
What was Predictive Oncology Inc’s price range in the past 12 months?
Predictive Oncology Inc lowest stock price was $1.35 and its highest was $7.12 in the past 12 months.
What is Predictive Oncology Inc’s market cap?
Currently, no data Available
When is Predictive Oncology Inc’s upcoming earnings report date?
Predictive Oncology Inc’s upcoming earnings report date is May 14, 2024 which is in 19 days.
How were Predictive Oncology Inc’s earnings last quarter?
Predictive Oncology Inc released its earnings results on Mar 28, 2024. The company reported -$0.86 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.86.
Is Predictive Oncology Inc overvalued?
According to Wall Street analysts Predictive Oncology Inc’s price is currently Overvalued.
Does Predictive Oncology Inc pay dividends?
Predictive Oncology Inc does not currently pay dividends.
What is Predictive Oncology Inc’s EPS estimate?
Predictive Oncology Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Predictive Oncology Inc have?
Predictive Oncology Inc has 4,062,853 shares outstanding.
What happened to Predictive Oncology Inc’s price movement after its last earnings report?
Predictive Oncology Inc reported an EPS of -$0.86 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -10.98%.
Which hedge fund is a major shareholder of Predictive Oncology Inc?
Currently, no hedge funds are holding shares in POAI
---
Predictive Oncology Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
POAI Sentiment 100%
Sector Average 70%
Sector Average 70%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.2%
Last 30 Days ▼ 9.3%
Last 30 Days ▼ 9.3%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-80.13%
12-Months-Change
Fundamentals
Return on Equity
-93.11%
Trailing 12-Months
Asset Growth
-43.98%
Trailing 12-Months
Company Description
Predictive Oncology Inc
Predictive Oncology, Inc. engages in the manufacture and distribution of healthcare products, and provision of related services. The company offers STREAMWAY System, which is an automated system for the collection and disposal of infectious fluids from surgical and other medical procedures. It operates through the Medical Device and Consumable Products segments. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
---
POAI Earnings Call
Q4 2024
0:00 / 0:00
---
Technical Analysis
Brainstorm Cell Therapeutics
―
Galectin Therapeutics
―
Jaguar Animal Health
―
Protagonist Therapeutics
―
---